Author

Bradley A. Stohr

University of California, San FranciscoORCID 0000-0002-5836-2624Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 3 Organism:human· 3 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Approach:deep learning· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1

Frequent Co-Authors

Arun P. WiitaiD· 2 shared Felix Yi-Chung FengiD· 2 shared Jonathan ChouiD· 2 shared Abhilash BarpandaiD· 1 shared Aidan Winters· 1 shared An Nguyen· 1 shared Arun A. Chandrakumar· 1 shared Ashutosh MaheshwariiD· 1 shared

Activity by Year

2025-2025 · peak 3/yr

Co-Author Collaboration Network

10 top collaborators · 31 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Arun P. WiitaORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Cancer BiologyNature GeneticsPeer-reviewedNov 5, 2025

Genome-wide CRISPR screens identify PTGES3 as a novel AR modulator

Haolong Li, James E. Melnyk, Becky Xu Hua Fu…·Felix Yi-Chung Feng

This study uses CRISPR screens to identify PTGES3 as a novel modulator of AR protein levels and function in prostate cancer, showing its role in therapy resistance.

10 citationstop 2%

humangenetic perturbation / CRISPR

𝕏 PostBluesky

Cancer BiologyNature CommunicationsPeer-reviewedJun 17, 2025

Histologic variants in bladder cancer harbor aggressive molecular features including TM4SF1 expression and a CA125+ cell state

Heiko Yang, Hanbing Song, Elizabeth Yip…·Franklin W. Huang

Single cell RNA sequencing of bladder cancer subtypes identified a CA125+ cell state linked to aggressive features and TM4SF1 as a therapeutic target.

16 citationstop 1%

humanscRNA-seq

𝕏 PostBluesky

Cancer BiologybioRxivPreprintMar 17, 2025

Reconstructing tumor evolution without chromosomal instability reveals in vivo determinants of therapeutic response

Ruhollah Moussavi-Baygi, Matthew J. Ryan, Woogwang Sim…·Rohit Bose

This study develops an in vivo platform called SETs to reconstruct tumor evolution without chromosomal instability, identifying therapeutic response determinants in prostate cancer.

1 citation

humanwhole-genome sequencing

𝕏 PostBluesky